Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review (Q37039136)

17 August 2017

Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review (English)

1 reference

Uterine clear cell carcinoma

17 August 2017

1 reference

1 reference

Thomas M

1

1 reference

17 August 2017

Mariani A

2

1 reference

17 August 2017

Wright JD

3

1 reference

17 August 2017

Madarek EO

4

1 reference

17 August 2017

Powell MA

5

1 reference

17 August 2017

Mutch DG

6

1 reference

17 August 2017

Podratz KC

7

1 reference

17 August 2017

Dowdy SC

8

1 reference

17 August 2017

language of work or name

English

0 references

publication date

21 December 2007

1 reference

17 August 2017

1 reference

17 August 2017

108

1 reference

17 August 2017

2

1 reference

17 August 2017

293-297

1 reference

The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Carcinoma of the endometrium: I. A clinicopathologic study of clear-cell carcinoma and secretory carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Clear cell carcinoma of the endometrium: an analysis of 21 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Role of cytoreduction in stage III and IV uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Predictors of vaginal relapse in stage I endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Assessment of prognostic factors in stage IIIA endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

The role of surgical cytoreduction in Stage IV endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

Surgical stage IV endometrial carcinoma: a study of 47 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.11.008

10.1016/J.YGYNO.2007.11.008

7 January 2021

Identifiers

DOI

1 reference

17 August 2017

1 reference